Cargando…

Subcutaneous Progesterone Is Effective and Safe for Luteal Phase Support in IVF: An Individual Patient Data Meta-Analysis of the Phase III Trials

OBJECTIVE: To summarize efficacy and safety data on a new progesterone compound which is available for subcutaneous administration as compared to vaginally administered progesterone for luteal phase support in patients undergoing IVF treatment. DESIGN: Data from two randomized phase III trials (07EU...

Descripción completa

Detalles Bibliográficos
Autores principales:	Doblinger, Jakob, Cometti, Barbara, Trevisan, Silvia, Griesinger, Georg
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4798618/ https://www.ncbi.nlm.nih.gov/pubmed/26991890 http://dx.doi.org/10.1371/journal.pone.0151388

Ejemplares similares

Dydrogesterone as an oral alternative to vaginal progesterone for IVF luteal phase support: A systematic review and individual participant data meta-analysis
por: Griesinger, Georg, et al.
Publicado: (2020)

A randomized, controlled trial comparing the efficacy and safety of aqueous subcutaneous progesterone with vaginal progesterone for luteal phase support of in vitro fertilization
por: Baker, Valerie L., et al.
Publicado: (2014)

Oral dydrogesterone versus intravaginal micronized progesterone gel for luteal phase support in IVF: a randomized clinical trial
por: Griesinger, Georg, et al.
Publicado: (2018)

Luteal Phase Support Using Subcutaneous Progesterone: A Systematic Review
por: Conforti, Alessandro, et al.
Publicado: (2021)

Do early luteal serum progesterone levels predict the reproductive outcomes in IVF with oral dydrogesterone for luteal phase support?
por: Netter, Antoine, et al.
Publicado: (2019)

A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization
por: Tournaye, Herman, et al.
Publicado: (2017)

Subcutaneous progesterone versus vaginal progesterone for luteal phase support in in vitro fertilization: A retrospective analysis from daily clinical practice
por: Schütt, Marcel, et al.
Publicado: (2021)

Subcutaneous progesterone versus vaginal progesterone for luteal-phase support in frozen-thawed embryo transfer: A cross-sectional study
por: Aflatoonian, Abbas, et al.
Publicado: (2021)

Endometrial thickness on the day of embryo transfer is a poor predictor of IVF treatment outcome
por: Griesinger, Georg, et al.
Publicado: (2018)

When Can We Safely Stop Luteal Phase Support in Fresh IVF Cycles? A Literature Review
por: Mizrachi, Yossi, et al.
Publicado: (2020)

Luteal phase bleeding after IVF cycles: comparison between progesterone vaginal gel and intramuscular progesterone and correlation with pregnancy outcomes
por: Jabara, Sami, et al.
Publicado: (2009)

Comparison of oral dydrogesterone with suppository vaginal progesterone for luteal-phase support in in vitro fertilization (IVF): A randomized clinical trial
por: Salehpour, Saghar, et al.
Publicado: (2013)

Comparison of Subcutaneous and Vaginal Progesterone Used for Luteal Phase Support in Patients Undergoing Intracytoplasmic Sperm Injection Cycles
por: Salehpour, Saghar, et al.
Publicado: (2021)

Reply: Endometrial thickness performs poorly as a predictor of IVF outcome, but does the endometrial receptivity array perform any better?
por: Griesinger, Georg, et al.
Publicado: (2020)

Comparison of intramuscular versus subcutaneous aqueous progesterone for luteal phase support in artificially prepared frozen embryo transfer cycles
por: Turgut, Emre Niyazi, et al.
Publicado: (2020)

Adding Weekly Intramuscular Progesterone to a Twice Daily Vaginal Progesterone Capsule for Luteal Phase Support in IVF/ICSI Cycles Results in Similar Live Birth Rates
por: Gari, Salwa, et al.
Publicado: (2022)

Patients’ administration preferences: progesterone vaginal insert (Endometrin®) compared to intramuscular progesterone for Luteal phase support
por: Beltsos, Angeline N, et al.
Publicado: (2014)

Evaluation of the impact of gonadotropin-releasing hormone agonist as an adjuvant in luteal-phase support on IVF outcome
por: Inamdar, Dattaprasad B, et al.
Publicado: (2012)

Luteal Phase Support in IVF: Comparison Between Evidence-Based Medicine and Real-Life Practices
por: Di Guardo, Federica, et al.
Publicado: (2020)

Assessment of progesterone levels on the day of pregnancy test determination: A novel concept toward individualized luteal phase support
por: Racca, A., et al.
Publicado: (2023)

Phase III trial of 8% vaginal progesterone gel for luteal phase support in Japanese women undergoing in vitro fertilization and fresh embryo transfer cycles
por: Kokeguchi, Shoji, et al.
Publicado: (2016)

Luteal Phase Support in assisted reproductive technology treatment: focus on Endometrin® (progesterone) vaginal insert
por: Check, Jerome H
Publicado: (2009)

Comparison of intravaginal progesterone gel and intramuscular 17-α-hydroxyprogesterone caproate in luteal phase support
por: SATIR, FUNDA, et al.
Publicado: (2013)

Progesterone Hypersensitivity: A Challenge for Luteal Support
por: Gupta, Astha, et al.
Publicado: (2018)

A questionnaire-based audit to assess overall experience and convenience among patients using vaginal progesterone tablets (Lutigest(®)) for luteal phase support during IVF treatment
por: Heine, Polly, et al.
Publicado: (2017)

The impact of luteal phase support on endometrial estrogen and progesterone receptor expression: a randomized control trial
por: Brezina, Paul R, et al.
Publicado: (2012)

Progesterone administration for luteal phase deficiency in human reproduction: an old or new issue?
por: Palomba, Stefano, et al.
Publicado: (2015)

The effect of adding oral oestradiol to progesterone as luteal phase support in ART cycles – a randomized controlled study
por: Moini, Ashraf, et al.
Publicado: (2011)

Estrogen Supplementation to Progesterone as Luteal Phase Support in Patients Undergoing In Vitro Fertilization: Systematic Review and Meta-Analysis
por: Zhang, Xiao-Mei, et al.
Publicado: (2015)

The optimal route of progesterone administration for luteal phase support in a frozen embryo transfer: a systematic review
por: Almohammadi, Abdulla, et al.
Publicado: (2022)

Initiating luteal phase support with sc progesterone based on low serum progesterone on the transfer day in true natural cycle frozen embryo transfers
por: Demirel, Cem, et al.
Publicado: (2023)

Luteal phase support in intrauterine insemination cycles
por: Gün, İsmet, et al.
Publicado: (2016)

Editorial: Luteal Phase Support for Assisted Reproduction
por: Friedler, Shevach, et al.
Publicado: (2021)

The effect of luteal phase progesterone supplementation on natural frozen-thawed embryo transfer cycles
por: Kim, Chung-Hoon, et al.
Publicado: (2014)

Early- and Late-Luteal-Phase Estrogen and Progesterone Levels of Women with Premenstrual Dysphoric Disorder
por: Yen, Ju-Yu, et al.
Publicado: (2019)

Co-administration of GnRH agonists with vaginal progesterone compared to vaginal progesterone in luteal phase support of the frozen-thawed embryo transfer cycle: An RCT
por: Zareii, Afsoon, et al.
Publicado: (2021)

Prolonged luteal phase support with progesterone may increase papules and plaques of pregnancy frequency in pregnancies through in vitro fertilization()()
por: Dokuzeylul Gungor, Nur, et al.
Publicado: (2021)

Luteal Phase Support in Intrauterine Insemination Cycles: A Randomized Clinical Trial of Vaginal Versus Intramuscular Progesterone Administration
por: Azargoon, Azam, et al.
Publicado: (2022)

Addition of intramuscular to vaginal progesterone for luteal phase support in fresh embryo transfer cycles: A cross-sectional study
por: Jalaliani, Samaneh, et al.
Publicado: (2022)

A Comparison of Oral Dydrogesterone with Vaginal Progesterone for Luteal-Phase Support in In vitro Fertilization: A Randomized Controlled Trial
por: Naghshineh, Elham, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_agb2admm7ulg2pjbcdqtfi54m8